Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

92
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
92

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrophysiological characterization of the Bachmann bundle region using 3D electroanatomical mapping and peak frequency analysis during pacemaker lead implantation.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same author

Repolarization and Activation Mapping in Ventricular Tachycardia Ablation: The REDEEM Study.

JACC. Clinical electrophysiology·2026
Same author

Incidence, Mechanistic Insights, and Ablation of Atrial Tachycardia Occurring After Pulsed Field Ablation for Atrial Fibrillation: Results From a Large International Registry.

JACC. Clinical electrophysiology·2026
Same author

Pulsed field ablation for the interventional treatment of atrial fibrillation: a scientific statement of the European Heart Rhythm Association of the European Society of Cardiology, the Heart Rhythm Society, the Asia Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Digitally assisted learning in cardiac electrophysiology and cardiac implantable electronic devices: a Scientific Statement of the European Heart Rhythm Association of the ESC.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026

Related Experiment Video

Updated: Jul 29, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.3K

Left Bundle Branch Area Defibrillator (LBBAD): A First-in-Human Feasibility Study.

Wim L H Huybrechts1, Marco Bergonti2, Johan B Saenen1

  • 1Department of Cardiology, University Hospital Antwerp, Edegem, Belgium; Department GENCOR-Heart Rhythm Disorders, University of Antwerp, Antwerp, Belgium.

JACC. Clinical Electrophysiology
|May 24, 2023
PubMed
Summary

Left bundle branch area (LBBA) defibrillator (LBBAD) implantation is a feasible but complex procedure. This study demonstrated successful LBBAD implantation in 60% of patients, with no complications, paving the way for further development.

Keywords:
conduction system pacingfirst-in-humanimplantable cardioverter-defibrillatorleft bundle branch area defibrillationleft bundle branch area pacing

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.5K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K

Related Experiment Videos

Last Updated: Jul 29, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.3K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.5K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.7K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Device Technology

Background:

  • Left bundle branch area (LBBA) pacing is an emerging technique with potential benefits for patients requiring pacemakers and implantable cardioverter-defibrillators (ICDs).
  • Implanting ICD leads in the LBBA may reduce lead burden, potentially enhancing safety and reducing costs.
  • LBBA positioning for ICD leads has not been previously documented.

Purpose of the Study:

  • To assess the safety and feasibility of implanting an LBBA ICD lead.
  • To evaluate acute performance parameters of LBBA ICD lead implantation.

Main Methods:

  • A prospective, single-center feasibility study was conducted.
  • LBBA ICD lead implantation was attempted in patients indicated for an ICD.
  • Acute pacing parameters, electrocardiography data, and defibrillation testing were performed.

Main Results:

  • LBBA defibrillator (LBBAD) implantation was achieved in 3 out of 5 (60%) patients.
  • Successful left bundle or septal capture was achieved in 2/3 patients.
  • Successful defibrillation testing was performed in all 3 patients, with no lead-related complications.

Conclusions:

  • First-in-human evaluation indicates feasibility of LBBAD implantation.
  • Current implantation techniques are complex and time-consuming.
  • Further technological advancements and long-term outcome evaluations are warranted.